Anesth Analg

1. WILSON EA, Weinberg DL, Patel GP
   Intraoperative Anesthetic Strategies to Mitigate Early Allograft Dysfunction After Orthotopic Liver Transplantation: A Narrative Review.
   Anesth Analg. 2024 Mar 5. doi: 10.1213/ANE.0000000000006902.
   

   >> Share

   
   

   
   Ann Surg

2. 
   An Analysis of 10,000 Cases of Living Donor Liver Transplantation in Japan: Special Reference to the Graft-Versus-Recipient Weight Ratio and Donor Age: Erratum.
   Ann Surg. 2024;279:e3.
   

   >> Share

   
   

   
   Clin Transplant

3. ADJEI M, Wisel SA, Yang JD, Nissen NN, et al
   Implications of drug intoxication on donor utilization and outcomes in liver transplantation.
   Clin Transplant. 2024;38:e15276.
   

   >> Share

   
   

   
   Hepatology

4. CHAPMAN B, Wong D, Sinclair M, Hey P, et al
   Reversing malnutrition and low muscle strength with targeted enteral feeding in patients awaiting liver transplant: A randomized controlled trial.
   Hepatology. 2024 Mar 8. doi: 10.1097/HEP.0000000000000840.
   

   >> Share

   
   
5. CZIGANY Z, Putri AJ, Michalski CW, Mehrabi A, et al
   Letter to the editor: Portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation (PILOTTM): A randomized, open-label, clinical trial.
   Hepatology. 2024 Mar 5. doi: 10.1097/HEP.0000000000000811.
   

   >> Share

   
   
6. LUNSFORD KE, Panayotova G, Guarrera JV
   Response to Letter to the Editor on portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation (PILOT).
   Hepatology. 2024 Mar 5. doi: 10.1097/HEP.0000000000000815.
   

   >> Share

   
   

   
   J Hepatol

7. MARTIN-MATEOS R, Martinez-Arenas L, Carvalho-Gomes A, Aceituno L, et al
   Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.
   J Hepatol. 2024 Feb 28:S0168-8278(24)00128-4. doi: 10.1016/j.jhep.2024.
   

   >> Share

   
   

   
   Transpl Int

8. VANLERBERGHE BTK, van Malenstein H, Sainz-Barriga M, Jochmans I, et al
   Tacrolimus Drug Exposure Level and Smoking Are Modifiable Risk Factors for Early De Novo Malignancy After Liver Transplantation for Alcohol-Related Liver Disease.
   Transpl Int. 2024;37:12055.
   

   >> Share

   
   

   
   Transplant Proc

9. IMAOKA K, Ohira M, Hattori M, Chogahara I, et al
   Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular Carcinoma.
   Transplant Proc. 2024 Mar 4:S0041-1345(24)00129.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share